06 August 2019
Austempered Ductile Iron Production Technology From Base Material Produced By Ferro-Casting Industry In Indonesia
Rianti Dewi Wulansari Sulamet Ariobimo, 2003 University of Queensland Abstract The quality of... Read More
The Australia Awards are prestigious, transformational scholarships and short courses offered to emerging leaders for study, research and professional development in Australia
27 Nov 2017
Marselinus Ulu F, 2015
The University of Melbourne
Abstract
A deterministic within-host pharmacokinetic-pharmacodynamic (PK–PD) model in the form of ordinary
differential equations (ODEs) has been generated to understand the artesunate resistance in Plasmodium
falciparum. Using mixed infection assumption, where a single host is infected with artesunate-sensitive
strains and artesunate-resistance strains at time t, we are able to understand the basic characteristics
of some available anti-malarial drugs and the mechanism of the standard three-day artemisinin-based
combination therapy (ACT) treatment protocol recommended by World Health Organisation (WHO) for
uncomplicated falciparum malaria treatment. More importantly, this simpler model is able to describe
how the three-day ACT treatment protocol is fail for treating a single patient with mixed parasite strains
in the bloodstream. It also enables us to propose other alternative treatment strategies to treat a patient
who is infected with resistant strains. It suggests that giving artesunate twice a day in the three-day
(ACT) treatment and administering the fourth dose of artesunate are the best treatment strategies that
can be applied to clear the artesunate-resistant strains.
Share this article on:
This website uses cookies to improve your website experience. We may also use cookies to analyse website data so that we can improve our online services. To find out more visit our privacy policy.